Physician profile
Michael A Ruzek
NPI 1275834830
$566.05
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $31.45 · 2022: $27.96 · 2023: $229 · 2024: $15.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $244.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Portola Pharmaceuticals, LLC | $137.62 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $124.51 | 2019 | |
| Inari Medical, INC. | $91.01 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bioxcel Therapeutics, INC. | $72.14 | 2023 | Igalmi |
| Allergan, INC. | $31.45 | 2020 | |
| Abbvie INC. | $27.96 | 2022 | |
| Csl Behring | $26.28 | 2023 | Kcentra |
| Pfizer INC. | $25.72 | 2023 | |
| Smith+Nephew, INC. | $15.37 | 2024 | Tc-100 |
| Indivior INC. | $13.99 | 2023 | Perseris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ruzek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.